We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$86.1B
AUM Growth
+$2.33B
(+2.8%)
Cap. Flow
-$1.4B
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
15.72%
Holding
1,869
New
68
Increased
904
Reduced
795
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$325M |
| 2 |
NBIS
Nebius Group N.V.
NBIS
|
+$319M |
| 3 |
Williams Companies
WMB
|
+$313M |
| 4 |
TGE
Tallgrass Energy, LP Class A Shares
TGE
|
+$303M |
| 5 |
Pinduoduo
PDD
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$937M |
| 2 |
AET
Aetna Inc
AET
|
+$561M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
+$296M |
| 4 |
JD.com
JD
|
+$295M |
| 5 |
TEP
Tallgrass Energy Partners, LP
TEP
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.01% |
| 2 | Healthcare | 14.62% |
| 3 | Consumer Discretionary | 14.06% |
| 4 | Financials | 13.33% |
| 5 | Energy | 12.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
G-III Apparel Group
GIII
$1.52B
| $18.6M | 0.02% |
386,941
+9,957
| +3% | +$452K |
|
602
Jazz Pharmaceuticals
JAZZ
$16B
| $18.6M | 0.02% |
110,678
-7,060
| -6% | -$1.21M |
|
603
Agnico Eagle Mines
AEM
$73B
| $18.6M | 0.02% |
543,000
-74,000
| -12% | -$2.88M |
|
|
DISH
604
DELISTED
DISH Network Corp.
DISH
| $18.3M | 0.02% |
513,130
-4,745
| -0.9% | -$163K |
|
|
CLR
605
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $18.3M | 0.02% |
+268,075
| New | +$16.9M |
|
606
Fair Isaac
FICO
$29.7B
| $18.3M | 0.02% |
80,078
+78,572
| +5,217% | +$17M |
|
607
CVS Health
CVS
$137B
| $18.2M | 0.02% |
231,502
-21,777
| -9% | -$1.56M |
|
608
Agios Pharmaceuticals
AGIO
$2.2B
| $18.2M | 0.02% |
235,975
+52,840
| +29% | +$4.25M |
|
|
NAV
609
DELISTED
Navistar International
NAV
| $18.2M | 0.02% |
472,622
+22,523
| +5% | +$939K |
|
610
Halozyme
HALO
$9.66B
| $18.2M | 0.02% |
1,000,000
| – | – |
|
611
Marvell Technology
MRVL
$170B
| $18.1M | 0.02% |
940,094
-889,079
| -49% | -$18.3M |
|
612
OceanFirst Financial
OCFC
$1.7B
| $18.1M | 0.02% |
665,430
+20,586
| +3% | +$601K |
|
613
State Street
STT
$50.7B
| $17.8M | 0.02% |
212,598
+2,487
| +1% | +$219K |
|
614
Xeris Biopharma Holdings
XERS
$1.42B
| $17.6M | 0.02% |
1,000,000
| – | – |
|
615
CBRE Group
CBRE
$42.1B
| $17.5M | 0.02% |
396,255
+93,268
| +31% | +$4.45M |
|
616
Gates Industrial Corporation Ltd.
GTES
$6.72B
| $17.5M | 0.02% |
895,530
+83,979
| +10% | +$1.47M |
|
|
XYZ
617
Block Inc
XYZ
$48.4B
| $17.4M | 0.02% |
176,228
-44,994
| -20% | -$3.47M |
|
|
AQUA
618
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $17.4M | 0.02% |
+979,900
| New | +$19.2M |
|
|
NFX
619
DELISTED
Newfield Exploration
NFX
| $17.3M | 0.02% |
599,994
+1,241
| +0.2% | +$34.9K |
|
|
GWPH
620
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $17.3M | 0.02% |
100,000
| – | – |
|
621
BioMarin Pharmaceuticals
BMRN
$11.6B
| $17.3M | 0.02% |
178,131
| – | – |
|
622
IQVIA
IQV
$35.6B
| $17.2M | 0.02% |
132,906
-923
| -0.7% | -$111K |
|
|
WMGI
623
DELISTED
Wright Medical Group Inc
WMGI
| $17.1M | 0.02% |
590,355
-72,676
| -11% | -$1.96M |
|
624
Medpace
MEDP
$16.5B
| $17.1M | 0.02% |
+285,370
| New | +$15.6M |
|
625
Archer Daniels Midland
ADM
$40.1B
| $17M | 0.02% |
337,902
+223,308
| +195% | +$11M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2018 Portfolio in Review
As of Q3 2018, OppenheimerFunds held 1,869 positions worth $86.1B, up 2.8% from $83.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
OppenheimerFunds's Q3 2018 filing shows 68 new, 904 increased, 795 reduced and 59 closed positions. Its largest new stake was Pinduoduo: 13,524,290 shares worth $356M. The largest sale was Trip.com Group, an estimated $937M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- OppenheimerFunds's largest Q3 2018 buy was Pinduoduo: 13,524,290 shares worth $356M.
- OppenheimerFunds added most to Prologis in Q3 2018, an estimated $325M increase.
- OppenheimerFunds's biggest Q3 2018 reduction was Aetna Inc, cutting an estimated $561M.
- OppenheimerFunds fully exited Trip.com Group in Q3 2018, selling an estimated $937M.
- OppenheimerFunds's ten largest holdings make up 16% of its $86.1B portfolio in Q3 2018.
- OppenheimerFunds opened 68 new positions and closed 59 in Q3 2018.
- OppenheimerFunds's portfolio value rose 2.8% quarter-over-quarter to $86.1B.
Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.